Global Digital Pathology

Digital Pathology Comprehensive Study by Type (Whole Slide Imaging, Image Analysis Informatics, Information Management System Storage & Communication, Digital IVD Devices, Others (Telepathology)), Application (Educational, Clinical, Pharma & Biotech Companies), Technology (Automated Hematology Analyzers & Blood Cell Counters, Chromosome Analyzers, Fish Enumeration Systems, Urine Sediment Analyzers, Immunohistochemistry Image Analysis Applications, Digital Cytopathology, Others) Players and Region - Global Market Outlook to 2030

Digital Pathology Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 11.98%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Digital Pathology
Digital pathology includes the acquisition, management, sharing and interpretation of pathology information generated from digital slides in a digital environment. Digital slides are generated when glass slides are represented with a scanning device, to give a high-resolution digital image that can be seen on a computer screen or mobile device. A digital slide image produced which used for high resolution image viewing, interpretation of data and image analysis of digital pathology slides. In Healthcare applications, clinical research, primary diagnosis, diagnostic consultation, intraoperative diagnosis and manual & semi-quantitative review of immunohistochemistry (IHC) are included. Digital pathology is an innovation committed towards in enhancement in productivity, improvement in operational efficiency, improving decision of treatment & patient care and reduction in laboratory expenses.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR11.98%


Competition among existing players is due to the Digital Pathology market share occupied by leading players. The industry leader is engaged in offering innovative and superior quality products to cater to the ever-growing demand for Digital Pathology Market. The companies are implementing strategic activities such as acquisitions and mergers along with collaboration with companies in other industries to aid them in improving sustenance and maintaining their competitive advantage. Analyst at AMA Research estimates that United Stated Players will contribute the maximum growth to Global Digital Pathology market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Danaher Corporation (United States), Digipath (United States), Glencoe Software (United States), Hamamatsu Photonics (Japan), Indica Labs (United States), Koninklijke Philips (Netherland), Nikon Corporation (Japan), PerkinElmer (United States), Visiopharm (Denmark), Leica Biosystems (Germany), Ventana Medical Systems (United States) and HCL Technologies (India) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Pathology Devices (United States), Biogeniux (India), 3DHISTECH (Hungray), OptraSCAN (India), Pathcore (Canada) and Others.

Segmentation Overview
AMA Research has segmented the market of Global Digital Pathology market by Type (Whole Slide Imaging, Image Analysis Informatics, Information Management System Storage & Communication, Digital IVD Devices and Others (Telepathology)), Application (Educational, Clinical and Pharma & Biotech Companies) and Region.



On the basis of geography, the market of Digital Pathology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Technology, the sub-segment i.e. Automated Hematology Analyzers & Blood Cell Counters will boost the Digital Pathology market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Technological Advancement in Medical Software industry and Emergence of artificial intelligence technology in digital pathology

Market Growth Drivers:
Increasing Use of Digital Pathology in Drug Development, Digital Pathology Cutting Off the Expenses of Laboratory, Reduction in Human Error and Improved Accuracy in Accuracy with the Help of Digital Pathology and Increasing Potential of Digital Pathology in Different Field Such as Consultation and Tissue-Based Research

Challenges:
Digital Pathology Is Must Be Integrated Into A Clinical Setting, Rapid and Stable Scanning and The Collection and Storage of Huge Medical Data has Raised Question In Terms Of Maintaining High Data Security

Restraints:
High Cost of Digital Pathology Solution and Unfavorable Reimbursement Policies

Opportunities:
Different Fields Including Radiology, Artificial Intelligence And Pathology Are Collaborating To Create More Efficient Digital Platforms And Streamlining Workflows.

Market Leaders and their expansionary development strategies
In February 2019, Danaher Corporation announced that, the company acquired the Biopharma business of GE Life Sciences (GE Biopharma). GE Biopharma leading provider of instruments and software to support process development and manufacturing workflows of biopharmaceutical drugs.
In December 2022, Deciphex, a provider of pathology software and services, has announced the launch of it Digital Research Pathology Platform, Patholytix 3.0. The new platform, which aims to revolutionize the tools available to research pathologists globally, is designed to overcome the limits of Laboratory Information Management System (LIMS) software that allows users to effectively manage samples and associated data.


Key Target Audience
Pharmaceutical & Biotechnology Companies, Research Institutes, Software and hardware companies, Government Organizations, Business Consulting Firms and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Whole Slide Imaging
  • Image Analysis Informatics
  • Information Management System Storage & Communication
  • Digital IVD Devices
  • Others (Telepathology)
By Application
  • Educational
  • Clinical
  • Pharma & Biotech Companies
By Technology
  • Automated Hematology Analyzers & Blood Cell Counters
  • Chromosome Analyzers
  • Fish Enumeration Systems
  • Urine Sediment Analyzers
  • Immunohistochemistry Image Analysis Applications
  • Digital Cytopathology
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Use of Digital Pathology in Drug Development
      • 3.2.2. Digital Pathology Cutting Off the Expenses of Laboratory
      • 3.2.3. Reduction in Human Error and Improved Accuracy in Accuracy with the Help of Digital Pathology
      • 3.2.4. Increasing Potential of Digital Pathology in Different Field Such as Consultation and Tissue-Based Research
    • 3.3. Market Challenges
      • 3.3.1. Digital Pathology Is Must Be Integrated Into A Clinical Setting, Rapid and Stable Scanning
      • 3.3.2. The Collection and Storage of Huge Medical Data has Raised Question In Terms Of Maintaining High Data Security
    • 3.4. Market Trends
      • 3.4.1. Technological Advancement in Medical Software industry
      • 3.4.2. Emergence of artificial intelligence technology in digital pathology
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Digital Pathology, by Type, Application, Technology and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Digital Pathology (Value)
      • 5.2.1. Global Digital Pathology by: Type (Value)
        • 5.2.1.1. Whole Slide Imaging
        • 5.2.1.2. Image Analysis Informatics
        • 5.2.1.3. Information Management System Storage & Communication
        • 5.2.1.4. Digital IVD Devices
        • 5.2.1.5. Others (Telepathology)
      • 5.2.2. Global Digital Pathology by: Application (Value)
        • 5.2.2.1. Educational
        • 5.2.2.2. Clinical
        • 5.2.2.3. Pharma & Biotech Companies
      • 5.2.3. Global Digital Pathology by: Technology (Value)
        • 5.2.3.1. Automated Hematology Analyzers & Blood Cell Counters
        • 5.2.3.2. Chromosome Analyzers
        • 5.2.3.3. Fish Enumeration Systems
        • 5.2.3.4. Urine Sediment Analyzers
        • 5.2.3.5. Immunohistochemistry Image Analysis Applications
        • 5.2.3.6. Digital Cytopathology
        • 5.2.3.7. Others
      • 5.2.4. Global Digital Pathology Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Digital Pathology: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Danaher Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Digipath (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Glencoe Software (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Hamamatsu Photonics (Japan)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Indica Labs (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Koninklijke Philips (Netherland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Nikon Corporation (Japan)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. PerkinElmer (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Visiopharm (Denmark)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Leica Biosystems (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Ventana Medical Systems (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. HCL Technologies (India)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Digital Pathology Sale, by Type, Application, Technology and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Digital Pathology (Value)
      • 7.2.1. Global Digital Pathology by: Type (Value)
        • 7.2.1.1. Whole Slide Imaging
        • 7.2.1.2. Image Analysis Informatics
        • 7.2.1.3. Information Management System Storage & Communication
        • 7.2.1.4. Digital IVD Devices
        • 7.2.1.5. Others (Telepathology)
      • 7.2.2. Global Digital Pathology by: Application (Value)
        • 7.2.2.1. Educational
        • 7.2.2.2. Clinical
        • 7.2.2.3. Pharma & Biotech Companies
      • 7.2.3. Global Digital Pathology by: Technology (Value)
        • 7.2.3.1. Automated Hematology Analyzers & Blood Cell Counters
        • 7.2.3.2. Chromosome Analyzers
        • 7.2.3.3. Fish Enumeration Systems
        • 7.2.3.4. Urine Sediment Analyzers
        • 7.2.3.5. Immunohistochemistry Image Analysis Applications
        • 7.2.3.6. Digital Cytopathology
        • 7.2.3.7. Others
      • 7.2.4. Global Digital Pathology Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Digital Pathology: by Type(USD Million)
  • Table 2. Digital Pathology Whole Slide Imaging , by Region USD Million (2018-2023)
  • Table 3. Digital Pathology Image Analysis Informatics , by Region USD Million (2018-2023)
  • Table 4. Digital Pathology Information Management System Storage & Communication , by Region USD Million (2018-2023)
  • Table 5. Digital Pathology Digital IVD Devices , by Region USD Million (2018-2023)
  • Table 6. Digital Pathology Others (Telepathology) , by Region USD Million (2018-2023)
  • Table 7. Digital Pathology: by Application(USD Million)
  • Table 8. Digital Pathology Educational , by Region USD Million (2018-2023)
  • Table 9. Digital Pathology Clinical , by Region USD Million (2018-2023)
  • Table 10. Digital Pathology Pharma & Biotech Companies , by Region USD Million (2018-2023)
  • Table 11. Digital Pathology: by Technology(USD Million)
  • Table 12. Digital Pathology Automated Hematology Analyzers & Blood Cell Counters , by Region USD Million (2018-2023)
  • Table 13. Digital Pathology Chromosome Analyzers , by Region USD Million (2018-2023)
  • Table 14. Digital Pathology Fish Enumeration Systems , by Region USD Million (2018-2023)
  • Table 15. Digital Pathology Urine Sediment Analyzers , by Region USD Million (2018-2023)
  • Table 16. Digital Pathology Immunohistochemistry Image Analysis Applications , by Region USD Million (2018-2023)
  • Table 17. Digital Pathology Digital Cytopathology , by Region USD Million (2018-2023)
  • Table 18. Digital Pathology Others , by Region USD Million (2018-2023)
  • Table 19. South America Digital Pathology, by Country USD Million (2018-2023)
  • Table 20. South America Digital Pathology, by Type USD Million (2018-2023)
  • Table 21. South America Digital Pathology, by Application USD Million (2018-2023)
  • Table 22. South America Digital Pathology, by Technology USD Million (2018-2023)
  • Table 23. Brazil Digital Pathology, by Type USD Million (2018-2023)
  • Table 24. Brazil Digital Pathology, by Application USD Million (2018-2023)
  • Table 25. Brazil Digital Pathology, by Technology USD Million (2018-2023)
  • Table 26. Argentina Digital Pathology, by Type USD Million (2018-2023)
  • Table 27. Argentina Digital Pathology, by Application USD Million (2018-2023)
  • Table 28. Argentina Digital Pathology, by Technology USD Million (2018-2023)
  • Table 29. Rest of South America Digital Pathology, by Type USD Million (2018-2023)
  • Table 30. Rest of South America Digital Pathology, by Application USD Million (2018-2023)
  • Table 31. Rest of South America Digital Pathology, by Technology USD Million (2018-2023)
  • Table 32. Asia Pacific Digital Pathology, by Country USD Million (2018-2023)
  • Table 33. Asia Pacific Digital Pathology, by Type USD Million (2018-2023)
  • Table 34. Asia Pacific Digital Pathology, by Application USD Million (2018-2023)
  • Table 35. Asia Pacific Digital Pathology, by Technology USD Million (2018-2023)
  • Table 36. China Digital Pathology, by Type USD Million (2018-2023)
  • Table 37. China Digital Pathology, by Application USD Million (2018-2023)
  • Table 38. China Digital Pathology, by Technology USD Million (2018-2023)
  • Table 39. Japan Digital Pathology, by Type USD Million (2018-2023)
  • Table 40. Japan Digital Pathology, by Application USD Million (2018-2023)
  • Table 41. Japan Digital Pathology, by Technology USD Million (2018-2023)
  • Table 42. India Digital Pathology, by Type USD Million (2018-2023)
  • Table 43. India Digital Pathology, by Application USD Million (2018-2023)
  • Table 44. India Digital Pathology, by Technology USD Million (2018-2023)
  • Table 45. South Korea Digital Pathology, by Type USD Million (2018-2023)
  • Table 46. South Korea Digital Pathology, by Application USD Million (2018-2023)
  • Table 47. South Korea Digital Pathology, by Technology USD Million (2018-2023)
  • Table 48. Taiwan Digital Pathology, by Type USD Million (2018-2023)
  • Table 49. Taiwan Digital Pathology, by Application USD Million (2018-2023)
  • Table 50. Taiwan Digital Pathology, by Technology USD Million (2018-2023)
  • Table 51. Australia Digital Pathology, by Type USD Million (2018-2023)
  • Table 52. Australia Digital Pathology, by Application USD Million (2018-2023)
  • Table 53. Australia Digital Pathology, by Technology USD Million (2018-2023)
  • Table 54. Rest of Asia-Pacific Digital Pathology, by Type USD Million (2018-2023)
  • Table 55. Rest of Asia-Pacific Digital Pathology, by Application USD Million (2018-2023)
  • Table 56. Rest of Asia-Pacific Digital Pathology, by Technology USD Million (2018-2023)
  • Table 57. Europe Digital Pathology, by Country USD Million (2018-2023)
  • Table 58. Europe Digital Pathology, by Type USD Million (2018-2023)
  • Table 59. Europe Digital Pathology, by Application USD Million (2018-2023)
  • Table 60. Europe Digital Pathology, by Technology USD Million (2018-2023)
  • Table 61. Germany Digital Pathology, by Type USD Million (2018-2023)
  • Table 62. Germany Digital Pathology, by Application USD Million (2018-2023)
  • Table 63. Germany Digital Pathology, by Technology USD Million (2018-2023)
  • Table 64. France Digital Pathology, by Type USD Million (2018-2023)
  • Table 65. France Digital Pathology, by Application USD Million (2018-2023)
  • Table 66. France Digital Pathology, by Technology USD Million (2018-2023)
  • Table 67. Italy Digital Pathology, by Type USD Million (2018-2023)
  • Table 68. Italy Digital Pathology, by Application USD Million (2018-2023)
  • Table 69. Italy Digital Pathology, by Technology USD Million (2018-2023)
  • Table 70. United Kingdom Digital Pathology, by Type USD Million (2018-2023)
  • Table 71. United Kingdom Digital Pathology, by Application USD Million (2018-2023)
  • Table 72. United Kingdom Digital Pathology, by Technology USD Million (2018-2023)
  • Table 73. Netherlands Digital Pathology, by Type USD Million (2018-2023)
  • Table 74. Netherlands Digital Pathology, by Application USD Million (2018-2023)
  • Table 75. Netherlands Digital Pathology, by Technology USD Million (2018-2023)
  • Table 76. Rest of Europe Digital Pathology, by Type USD Million (2018-2023)
  • Table 77. Rest of Europe Digital Pathology, by Application USD Million (2018-2023)
  • Table 78. Rest of Europe Digital Pathology, by Technology USD Million (2018-2023)
  • Table 79. MEA Digital Pathology, by Country USD Million (2018-2023)
  • Table 80. MEA Digital Pathology, by Type USD Million (2018-2023)
  • Table 81. MEA Digital Pathology, by Application USD Million (2018-2023)
  • Table 82. MEA Digital Pathology, by Technology USD Million (2018-2023)
  • Table 83. Middle East Digital Pathology, by Type USD Million (2018-2023)
  • Table 84. Middle East Digital Pathology, by Application USD Million (2018-2023)
  • Table 85. Middle East Digital Pathology, by Technology USD Million (2018-2023)
  • Table 86. Africa Digital Pathology, by Type USD Million (2018-2023)
  • Table 87. Africa Digital Pathology, by Application USD Million (2018-2023)
  • Table 88. Africa Digital Pathology, by Technology USD Million (2018-2023)
  • Table 89. North America Digital Pathology, by Country USD Million (2018-2023)
  • Table 90. North America Digital Pathology, by Type USD Million (2018-2023)
  • Table 91. North America Digital Pathology, by Application USD Million (2018-2023)
  • Table 92. North America Digital Pathology, by Technology USD Million (2018-2023)
  • Table 93. United States Digital Pathology, by Type USD Million (2018-2023)
  • Table 94. United States Digital Pathology, by Application USD Million (2018-2023)
  • Table 95. United States Digital Pathology, by Technology USD Million (2018-2023)
  • Table 96. Canada Digital Pathology, by Type USD Million (2018-2023)
  • Table 97. Canada Digital Pathology, by Application USD Million (2018-2023)
  • Table 98. Canada Digital Pathology, by Technology USD Million (2018-2023)
  • Table 99. Mexico Digital Pathology, by Type USD Million (2018-2023)
  • Table 100. Mexico Digital Pathology, by Application USD Million (2018-2023)
  • Table 101. Mexico Digital Pathology, by Technology USD Million (2018-2023)
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Digital Pathology: by Type(USD Million)
  • Table 115. Digital Pathology Whole Slide Imaging , by Region USD Million (2025-2030)
  • Table 116. Digital Pathology Image Analysis Informatics , by Region USD Million (2025-2030)
  • Table 117. Digital Pathology Information Management System Storage & Communication , by Region USD Million (2025-2030)
  • Table 118. Digital Pathology Digital IVD Devices , by Region USD Million (2025-2030)
  • Table 119. Digital Pathology Others (Telepathology) , by Region USD Million (2025-2030)
  • Table 120. Digital Pathology: by Application(USD Million)
  • Table 121. Digital Pathology Educational , by Region USD Million (2025-2030)
  • Table 122. Digital Pathology Clinical , by Region USD Million (2025-2030)
  • Table 123. Digital Pathology Pharma & Biotech Companies , by Region USD Million (2025-2030)
  • Table 124. Digital Pathology: by Technology(USD Million)
  • Table 125. Digital Pathology Automated Hematology Analyzers & Blood Cell Counters , by Region USD Million (2025-2030)
  • Table 126. Digital Pathology Chromosome Analyzers , by Region USD Million (2025-2030)
  • Table 127. Digital Pathology Fish Enumeration Systems , by Region USD Million (2025-2030)
  • Table 128. Digital Pathology Urine Sediment Analyzers , by Region USD Million (2025-2030)
  • Table 129. Digital Pathology Immunohistochemistry Image Analysis Applications , by Region USD Million (2025-2030)
  • Table 130. Digital Pathology Digital Cytopathology , by Region USD Million (2025-2030)
  • Table 131. Digital Pathology Others , by Region USD Million (2025-2030)
  • Table 132. South America Digital Pathology, by Country USD Million (2025-2030)
  • Table 133. South America Digital Pathology, by Type USD Million (2025-2030)
  • Table 134. South America Digital Pathology, by Application USD Million (2025-2030)
  • Table 135. South America Digital Pathology, by Technology USD Million (2025-2030)
  • Table 136. Brazil Digital Pathology, by Type USD Million (2025-2030)
  • Table 137. Brazil Digital Pathology, by Application USD Million (2025-2030)
  • Table 138. Brazil Digital Pathology, by Technology USD Million (2025-2030)
  • Table 139. Argentina Digital Pathology, by Type USD Million (2025-2030)
  • Table 140. Argentina Digital Pathology, by Application USD Million (2025-2030)
  • Table 141. Argentina Digital Pathology, by Technology USD Million (2025-2030)
  • Table 142. Rest of South America Digital Pathology, by Type USD Million (2025-2030)
  • Table 143. Rest of South America Digital Pathology, by Application USD Million (2025-2030)
  • Table 144. Rest of South America Digital Pathology, by Technology USD Million (2025-2030)
  • Table 145. Asia Pacific Digital Pathology, by Country USD Million (2025-2030)
  • Table 146. Asia Pacific Digital Pathology, by Type USD Million (2025-2030)
  • Table 147. Asia Pacific Digital Pathology, by Application USD Million (2025-2030)
  • Table 148. Asia Pacific Digital Pathology, by Technology USD Million (2025-2030)
  • Table 149. China Digital Pathology, by Type USD Million (2025-2030)
  • Table 150. China Digital Pathology, by Application USD Million (2025-2030)
  • Table 151. China Digital Pathology, by Technology USD Million (2025-2030)
  • Table 152. Japan Digital Pathology, by Type USD Million (2025-2030)
  • Table 153. Japan Digital Pathology, by Application USD Million (2025-2030)
  • Table 154. Japan Digital Pathology, by Technology USD Million (2025-2030)
  • Table 155. India Digital Pathology, by Type USD Million (2025-2030)
  • Table 156. India Digital Pathology, by Application USD Million (2025-2030)
  • Table 157. India Digital Pathology, by Technology USD Million (2025-2030)
  • Table 158. South Korea Digital Pathology, by Type USD Million (2025-2030)
  • Table 159. South Korea Digital Pathology, by Application USD Million (2025-2030)
  • Table 160. South Korea Digital Pathology, by Technology USD Million (2025-2030)
  • Table 161. Taiwan Digital Pathology, by Type USD Million (2025-2030)
  • Table 162. Taiwan Digital Pathology, by Application USD Million (2025-2030)
  • Table 163. Taiwan Digital Pathology, by Technology USD Million (2025-2030)
  • Table 164. Australia Digital Pathology, by Type USD Million (2025-2030)
  • Table 165. Australia Digital Pathology, by Application USD Million (2025-2030)
  • Table 166. Australia Digital Pathology, by Technology USD Million (2025-2030)
  • Table 167. Rest of Asia-Pacific Digital Pathology, by Type USD Million (2025-2030)
  • Table 168. Rest of Asia-Pacific Digital Pathology, by Application USD Million (2025-2030)
  • Table 169. Rest of Asia-Pacific Digital Pathology, by Technology USD Million (2025-2030)
  • Table 170. Europe Digital Pathology, by Country USD Million (2025-2030)
  • Table 171. Europe Digital Pathology, by Type USD Million (2025-2030)
  • Table 172. Europe Digital Pathology, by Application USD Million (2025-2030)
  • Table 173. Europe Digital Pathology, by Technology USD Million (2025-2030)
  • Table 174. Germany Digital Pathology, by Type USD Million (2025-2030)
  • Table 175. Germany Digital Pathology, by Application USD Million (2025-2030)
  • Table 176. Germany Digital Pathology, by Technology USD Million (2025-2030)
  • Table 177. France Digital Pathology, by Type USD Million (2025-2030)
  • Table 178. France Digital Pathology, by Application USD Million (2025-2030)
  • Table 179. France Digital Pathology, by Technology USD Million (2025-2030)
  • Table 180. Italy Digital Pathology, by Type USD Million (2025-2030)
  • Table 181. Italy Digital Pathology, by Application USD Million (2025-2030)
  • Table 182. Italy Digital Pathology, by Technology USD Million (2025-2030)
  • Table 183. United Kingdom Digital Pathology, by Type USD Million (2025-2030)
  • Table 184. United Kingdom Digital Pathology, by Application USD Million (2025-2030)
  • Table 185. United Kingdom Digital Pathology, by Technology USD Million (2025-2030)
  • Table 186. Netherlands Digital Pathology, by Type USD Million (2025-2030)
  • Table 187. Netherlands Digital Pathology, by Application USD Million (2025-2030)
  • Table 188. Netherlands Digital Pathology, by Technology USD Million (2025-2030)
  • Table 189. Rest of Europe Digital Pathology, by Type USD Million (2025-2030)
  • Table 190. Rest of Europe Digital Pathology, by Application USD Million (2025-2030)
  • Table 191. Rest of Europe Digital Pathology, by Technology USD Million (2025-2030)
  • Table 192. MEA Digital Pathology, by Country USD Million (2025-2030)
  • Table 193. MEA Digital Pathology, by Type USD Million (2025-2030)
  • Table 194. MEA Digital Pathology, by Application USD Million (2025-2030)
  • Table 195. MEA Digital Pathology, by Technology USD Million (2025-2030)
  • Table 196. Middle East Digital Pathology, by Type USD Million (2025-2030)
  • Table 197. Middle East Digital Pathology, by Application USD Million (2025-2030)
  • Table 198. Middle East Digital Pathology, by Technology USD Million (2025-2030)
  • Table 199. Africa Digital Pathology, by Type USD Million (2025-2030)
  • Table 200. Africa Digital Pathology, by Application USD Million (2025-2030)
  • Table 201. Africa Digital Pathology, by Technology USD Million (2025-2030)
  • Table 202. North America Digital Pathology, by Country USD Million (2025-2030)
  • Table 203. North America Digital Pathology, by Type USD Million (2025-2030)
  • Table 204. North America Digital Pathology, by Application USD Million (2025-2030)
  • Table 205. North America Digital Pathology, by Technology USD Million (2025-2030)
  • Table 206. United States Digital Pathology, by Type USD Million (2025-2030)
  • Table 207. United States Digital Pathology, by Application USD Million (2025-2030)
  • Table 208. United States Digital Pathology, by Technology USD Million (2025-2030)
  • Table 209. Canada Digital Pathology, by Type USD Million (2025-2030)
  • Table 210. Canada Digital Pathology, by Application USD Million (2025-2030)
  • Table 211. Canada Digital Pathology, by Technology USD Million (2025-2030)
  • Table 212. Mexico Digital Pathology, by Type USD Million (2025-2030)
  • Table 213. Mexico Digital Pathology, by Application USD Million (2025-2030)
  • Table 214. Mexico Digital Pathology, by Technology USD Million (2025-2030)
  • Table 215. Research Programs/Design for This Report
  • Table 216. Key Data Information from Secondary Sources
  • Table 217. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Digital Pathology: by Type USD Million (2018-2023)
  • Figure 5. Global Digital Pathology: by Application USD Million (2018-2023)
  • Figure 6. Global Digital Pathology: by Technology USD Million (2018-2023)
  • Figure 7. South America Digital Pathology Share (%), by Country
  • Figure 8. Asia Pacific Digital Pathology Share (%), by Country
  • Figure 9. Europe Digital Pathology Share (%), by Country
  • Figure 10. MEA Digital Pathology Share (%), by Country
  • Figure 11. North America Digital Pathology Share (%), by Country
  • Figure 12. Global Digital Pathology share by Players 2023 (%)
  • Figure 13. Global Digital Pathology share by Players (Top 3) 2023(%)
  • Figure 14. Global Digital Pathology share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 17. Danaher Corporation (United States) Revenue: by Geography 2023
  • Figure 18. Digipath (United States) Revenue, Net Income and Gross profit
  • Figure 19. Digipath (United States) Revenue: by Geography 2023
  • Figure 20. Glencoe Software (United States) Revenue, Net Income and Gross profit
  • Figure 21. Glencoe Software (United States) Revenue: by Geography 2023
  • Figure 22. Hamamatsu Photonics (Japan) Revenue, Net Income and Gross profit
  • Figure 23. Hamamatsu Photonics (Japan) Revenue: by Geography 2023
  • Figure 24. Indica Labs (United States) Revenue, Net Income and Gross profit
  • Figure 25. Indica Labs (United States) Revenue: by Geography 2023
  • Figure 26. Koninklijke Philips (Netherland) Revenue, Net Income and Gross profit
  • Figure 27. Koninklijke Philips (Netherland) Revenue: by Geography 2023
  • Figure 28. Nikon Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 29. Nikon Corporation (Japan) Revenue: by Geography 2023
  • Figure 30. PerkinElmer (United States) Revenue, Net Income and Gross profit
  • Figure 31. PerkinElmer (United States) Revenue: by Geography 2023
  • Figure 32. Visiopharm (Denmark) Revenue, Net Income and Gross profit
  • Figure 33. Visiopharm (Denmark) Revenue: by Geography 2023
  • Figure 34. Leica Biosystems (Germany) Revenue, Net Income and Gross profit
  • Figure 35. Leica Biosystems (Germany) Revenue: by Geography 2023
  • Figure 36. Ventana Medical Systems (United States) Revenue, Net Income and Gross profit
  • Figure 37. Ventana Medical Systems (United States) Revenue: by Geography 2023
  • Figure 38. HCL Technologies (India) Revenue, Net Income and Gross profit
  • Figure 39. HCL Technologies (India) Revenue: by Geography 2023
  • Figure 40. Global Digital Pathology: by Type USD Million (2025-2030)
  • Figure 41. Global Digital Pathology: by Application USD Million (2025-2030)
  • Figure 42. Global Digital Pathology: by Technology USD Million (2025-2030)
  • Figure 43. South America Digital Pathology Share (%), by Country
  • Figure 44. Asia Pacific Digital Pathology Share (%), by Country
  • Figure 45. Europe Digital Pathology Share (%), by Country
  • Figure 46. MEA Digital Pathology Share (%), by Country
  • Figure 47. North America Digital Pathology Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Danaher Corporation (United States)
  • Digipath (United States)
  • Glencoe Software (United States)
  • Hamamatsu Photonics (Japan)
  • Indica Labs (United States)
  • Koninklijke Philips (Netherland)
  • Nikon Corporation (Japan)
  • PerkinElmer (United States)
  • Visiopharm (Denmark)
  • Leica Biosystems (Germany)
  • Ventana Medical Systems (United States)
  • HCL Technologies (India)
Additional players considered in the study are as follows:
Pathology Devices (United States) , Biogeniux (India) , 3DHISTECH (Hungray) , OptraSCAN (India) , Pathcore (Canada) , Others
Select User Access Type

Key Highlights of Report


Apr 2024 228 Pages 92 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Digital Pathology Quantitative research analysis
Global Digital Pathology Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Danaher Corporation (United States), Digipath (United States), Glencoe Software (United States), Hamamatsu Photonics (Japan), Indica Labs (United States), Koninklijke Philips (Netherland), Nikon Corporation (Japan), PerkinElmer (United States), Visiopharm (Denmark), Leica Biosystems (Germany), Ventana Medical Systems (United States) and HCL Technologies (India) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Technological Advancement in Medical Software industry " is seen as one of major influencing trends for Digital Pathology Market during projected period 2023-2030.
The Digital Pathology market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Digital Pathology Report?

Have a Query? Click Here

Other Related Reports

Nerve Monitoring System Comprehensive Study by Application (Neurosurgery, ENT Surgery, Spine Surgery, Cardiovascular Surgery, Other), Technology (EEG Technology, EMG Technology, EP Technology, ECOG T...
$ 3450
Patient Portal Comprehensive Study by Type (Standalone Patient Portals, Integrated Patient Portals), Application (Providers, Payers, Pharmacies, Others) Players and Region - Global Market Outlook to ...
$ 3500
Blockchain technology in Healthcare Comprehensive Study by Type (Private Blockchain, Public Blockchain, Consortium Blockchain), End User (Healthcare Payers, Healthcare Providers, Pharmaceutical Compa...
$ 3350
Hemodialysis & Peritoneal Dialysis Comprehensive Study by Type (Hemodialysis (Conventional Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis), Peritoneal Dialysis (Continuous Ambulatory ...
$ 3750
Capsule Endoscopy Comprehensive Study by Type (Small Bowel Capsule, Esophageal Capsule, Colon Capsule), Application (Intestine Disease, Crohn’s Disease, GIT Bleeding, Others), Component (Wireless Cap...
$ 3750
Radiation Oncology Comprehensive Study by Type (External Beam Radiation Therapy, Brachytherapy, Systemic Beam Radiation Therapy, Others), Application (Blood Cancer (Leukaemia), Breast Cancer, Gastroi...
$ 3750